BIOIDENT Receive Frost and Sullivan Award for Expertise in Lab-on-a-Chip Platform

BIOIDENT Technologies Inc., the leading company in the development of printed optoelectronic solutions for life sciences, today announced that it is the recipient of the 2007 Frost & Sullivan Enabling Technology of the Year Award for its superior expertise in the lab-on-a-chip platform.

The distinguished award is presented to a company who has developed a solution that revolutionizes an industry and removes a significant stumbling block in the development of a technology. The award criteria also ensure that the enabling technology translates into a more efficient, cost effective and portable alternative for end-users.

“We are honored to be chosen for this prestigious award that recognizes our revolutionary, disposable lab-on-a-chip platform, which sets new standards in the industry,” said Dr. Wasiq Bokhari, CEO for BIOIDENT. “This acknowledgment validates BIOIDENT’s expertise in integrating microfluidics and organic photonics into a single solution and exemplifies the wide range capabilities of the technology in applications such as point-of-care diagnostics, water and food analysis and chemical and biological agent detection.”

BIOIDENT utilizes breakthroughs in science and nanotechnology to develop printed optoelectronic solutions that take lab-on-a-chip devices to the next level by integrating an optoelectronic read out system into the chip. The company uses established testing protocols to deliver real-time and in-situ multi-parameter detection capabilities for all categories of chemical and biological analytes, which expands its applications.

“BIOIDENT’s pioneering technology will transform the point-of-care-testing (POCT) and life science industry, especially as manufacturers seek devices that are user-friendly, provide superior test results and are available at a competitive price,” explains Arun AK, analyst for Frost & Sullivan. “With the company’s deep expertise, rapid production capability and innovative applications, BIOIDENT is poised to become a global leader in providing safe, breakthrough health care products.”

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Frost and Sullivan. (2019, March 19). BIOIDENT Receive Frost and Sullivan Award for Expertise in Lab-on-a-Chip Platform. AZoNano. Retrieved on November 21, 2024 from https://www.azonano.com/news.aspx?newsID=4085.

  • MLA

    Frost and Sullivan. "BIOIDENT Receive Frost and Sullivan Award for Expertise in Lab-on-a-Chip Platform". AZoNano. 21 November 2024. <https://www.azonano.com/news.aspx?newsID=4085>.

  • Chicago

    Frost and Sullivan. "BIOIDENT Receive Frost and Sullivan Award for Expertise in Lab-on-a-Chip Platform". AZoNano. https://www.azonano.com/news.aspx?newsID=4085. (accessed November 21, 2024).

  • Harvard

    Frost and Sullivan. 2019. BIOIDENT Receive Frost and Sullivan Award for Expertise in Lab-on-a-Chip Platform. AZoNano, viewed 21 November 2024, https://www.azonano.com/news.aspx?newsID=4085.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.